Timothy West, MD

702.483.6000

Timothy West, MD

Appointed: 2011

Timothy West, MD
Department: Cleveland Clinic Lou Ruvo Center for Brain Health
Location: Lou Ruvo Center for Brain Health
Mail Code Las Vegas
888 W. Bonneville
Las Vegas, NV 89106
WorkAppointment:702.483.6000
WorkFax:702.483.6007
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Director of the Multiple Sclerosis Program at Cleveland Clinic Lou Ruvo Center for Brain Health, Dr. West received his undergraduate degree in Neuroscience at Brigham Young University in Provo, Utah. He completed his medical degree and Neurology residency at the University of California, San Francisco. After serving as Chief Neurology Resident he stayed on to complete a fellowship in clinical neuroimmunology that was funded by the National MS Society.

Dr. West is very involved in clinical research and has experience running clinical trials within an MS Center. He has published original articles on Multiple Sclerosis relating to the safety of therapeutics and the clinical predictors within the early stages of the disease. His research interests are focused on improving patient outcomes and the development of novel therapeutics in the treatment of Multiple Sclerosis.

Aside from research, Dr. West has a great passion for teaching and has taught within the medical school at UC San Francisco for the past three years. He frequently participates in patient education programs and is very committed to providing comprehensive care for patients with Multiple Sclerosis. As such, part of his clinical fellowship included special training in neuro-urology, spasticity management and neurodiagnostics.

Published Articles:

West TW, Killestein J, Fox RJ. Natalizumab discontinuation: an increasingly tricky proposition. Eur J Neurol. 2011 Nov, Epub ahead of print

West TW, Cree BAC. Is there a role for planned natalizumab dosage suspension in mitigating progressive multifocal leukoencephalopathy risk? Neurodegen. Dis. Manage. 2011; 1(1):11-14

West TW, Cree BAC. Natalizumab dosage interruption: are we helping or hurting? Ann Neurol, 2010 Sep;68(3):395-9.

Johnson ECB, West T, Ko N, Strober J. A 41-Year-Old Man with New Headache and Altered Mental Status. Neurohospitalist, Jan 2011

T West, BS, M Wyatt, MS, A High, AB, A Bostrom, PhD and E Waubant, MD, PhD "Are initial demyelinating event recovery and time to second event under differential control?" Neurology 2006;67:809-813

Lephart, E.D., T.W. West, K.S. Weber, R.W. Rhees, K.D.R. Setchell, H. Adlercreutz, T.D. Lund. "Neurobehavioral Effects of Dietary Soy Phytoestrogens." Neurotoxicology and Teratology, 2002, 24: 1-12.

T.D. Lund, T.W. West, L.Y. Tian, L.H. Bu, D.L. Simmons, K.D.R. Setchell, H. Adlercreutz and E.D. Lephart. "Visual Spatial Memory is Enhanced in Females (but not in males) by Dietary Soy Phytoestrogens." BMC Neuroscience, 2001, 2:20 (1-19).

Education & Fellowships

Fellowship - University of California San Francisco Medical Center
Multiple Sclerosis/Neuroimmunology
San Francisco, CA USA
2011
Residency - University of California San Francisco Medical Center
Neurology
San Francisco, CA USA
2010
Internship - University of Utah Health Sciences Center
Internal Medicine
Salt Lake City, UT usa
2007
Medical School - University of California-San Francisco School of Medicine
San Francisco, CA USA
2006
Undergraduate - Brigham Young University
Provo, UT USA
2001

Certifications

  • Neurology

Specialty Interests

Multiple Sclerosis, Neuromyelitis Optica, Transverse Myelitis, Neuroimmunology

Memberships

American Academy of Neurology

Treatment & Services

  • Consultation, Evaluation, And Treatment Adult Neurological Disorders
  • Neurourology

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. West's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

Languages Spoken

  • English
  • Spanish
Cleveland Clinic Mobile Site